|
J Biol Chem, Vol. 274, Issue 48, 34103-34110, November 26, 1999
Cell Shrinkage Triggers the Activation of Mitogen-activated
Protein Kinases by Hypertonicity in the Rat Kidney Medullary Thick
Ascending Limb of the Henle's Loop
REQUIREMENT OF p38 KINASE FOR THE REGULATORY VOLUME INCREASE
RESPONSE*
Frank
Roger,
Pierre-Yves
Martin,
Martine
Rousselot,
Hervé
Favre, and
Eric
Féraille
From the Division de Néphrologie, Fondation pour Recherches
Médicales, 64 Ave de la Roseraie,
CH-1211 Genève 4, Switzerland
 |
ABSTRACT |
The kidney medulla is exposed to very high
interstitial osmolarity leading to the activation of mitogen-activated
protein kinases (MAPK). However, the respective roles of increased
intracellular osmolality and of cell shrinkage in MAPK activation are
not known. Similarly, the participation of MAPK in the regulatory
volume increase (RVI) following cell shrinkage remains to be
investigated. In the rat medullary thick ascending limb of Henle
(MTAL), extracellular hypertonicity produced by addition of NaCl or
sucrose increased the phosphorylation level of extracellular
signal-regulated kinase (ERK) and p38 kinase and to a lesser extent
c-Jun NH2-terminal kinase with sucrose only. Both
hypertonic solutions decreased the MTAL cellular volume in a dose- and
time-dependent manner. In contrast, hypertonic urea had no
effect. The extent of MAPK activation was correlated with the extent of
MTAL cellular volume decrease. Increasing intracellular osmolality
without modifying cellular volume did not activate MAPK, whereas cell
shrinkage without variation in osmolality activated both ERK and p38.
In the presence of 600 mosmol/liter NaCl, the maximal cell shrinkage was observed after 10 min at 37 °C and the MTAL cellular volume was
reduced to 70% of its initial value. Then, RVI occurred and the
cellular volume progressively recovered to reach about 90% of its
initial value after 30 min. SB203580, a specific inhibitor of p38,
almost completely inhibited the cellular volume recovery, whereas
inhibition of ERK did not alter RVI. In conclusion, in rat MTAL: 1)
cell shrinkage, but not intracellular hyperosmolality, triggers the
activation of both ERK and p38 kinase in response to extracellular
hypertonicity; and 2) RVI is dependent on p38 kinase activation.
 |
INTRODUCTION |
During diuresis and antidiuresis, the kidney medulla is exposed to
large fluctuations of interstitial osmolarity (1), which challenge cell
volume constancy. Cells of the medullary thick ascending limb of Henle
(MTAL)1 are of special
interest, since they are the major contributor to the generation of the
renal cortico-papillary osmotic gradient allowing urinary concentration
in terrestrial animals. The first adaptive process occurring in
response to extracellular hypertonicity-induced cell shrinkage is a
regulatory cell volume increase (RVI). The RVI results from the
stimulation of ion transporters which increase the intracellular ion
content within minutes and partially restore the cellular volume from
the initial cell shrinkage (2, 3). A second adaptive mechanism, in
mammalian cells, is the induction of genes encoding proteins involved
in the accumulation of intracellular "compatible osmolytes" within
hours and days. These osmoprotective proteins are either enzymes,
i.e. aldose reductase generating sorbitol from glucose, or
organic osmolytes transporters, i.e. myo-inositol, taurine,
glycerophosphocholine, and betaine (4). The intracellular signaling
pathways mediating these adaptive mechanisms, especially the role of
MAP kinases, are still incompletely understood.
Mitogen-activated protein (MAP) kinase cascades are important
intracellular signal-transduction pathways activated in response to
changes in osmolality. MAP kinases are serine/threonine kinases activated via a cascade of kinases involving a sequential
phosphorylation of two kinases (MAP kinase kinase kinase and MAP kinase
kinase), which activates a MAP kinase via a dual phosphorylation on
threonine and tyrosine residues (5). In mammalian cells, the MAP kinase family contains three major subgroups responding to distinct
extracellular stimuli: extracellular signal-regulated kinases 1 and 2 (ERK) principally activated by growth factors, integrin-matrix
interaction, and hormones or neurotransmitters with serpentine
receptors (6-12); c-Jun NH2-terminal kinases (JNK, also
known as stress-activated protein kinases 1); and p38 kinases (also
known as stress-activated protein kinases 2) strongly activated by
inflammatory cytokines, ultraviolet light, and hypertonic stress
(13-18). To date, the effects of MAP kinases have been mostly
attributed to the control of gene transcription via phosphorylation of
nuclear transcription factors (5, 13). However, non-genomic effects of
MAP kinases are increasingly recognized. ERKs may control glucose
metabolism through activation of p90rsk, which
phosphorylates and inhibits glycogen synthase kinase 3 (19, 20). In
addition, ERKs might be involved in the control of cAMP-specific
phosphodiesterase activity (21). On the other hand, p38 kinase might be
implicated in stress- and growth factor-induced cytoskeleton
reorganization (22, 23) and in the stimulation of glucose transport by
insulin (24).
Activation of the three families of MAP kinases by extracellular
hypertonicity has been shown in different cell lines in culture (18,
25-29), as well as in native rat MTAL cells (30), but the mechanisms
of their activation by extracellular hypertonicity need to be
clarified. Neither the respective role of intracellular hypertonicity
versus cell shrinkage in the activation of MAP kinases by
extracellular hyperosmolality nor the relationship between the MAP
kinase activation and the regulatory cell volume increase have been
investigated. We have undertaken this study: 1) to examine the effects
of different solutes on the activation of MAP kinases in MTAL cells by
hypertonicity, and 2) to analyze the relationship between MAP kinase
activation and cell volume variations.
 |
EXPERIMENTAL PROCEDURES |
Preparation of Single MTALs--
Male Wistar rats weighing
150-200 g were anesthetized with pentobarbital sodium (5 mg/100 g body
weight, intraperitoneally) and left kidney was immediately removed
after perfusion with ice-cold incubation solution (120 mM
NaCl, 5 mM RbCl, 4 mM NaHCO3, 1 mM CaCl2, 1 mM MgSO4,
0.2 mM NaH2PO4, 0.15 mM
Na2HPO4, 5 mM glucose, 10 mM lactate, 1 mM pyruvate, 4 mM
essential and nonessential amino acids, 0.03 mM vitamin, 20 mM HEPES, and 0.1% bovine serum albumin (BSA), pH 7.4)
containing 0.18% (w/v) collagenase. After incubation at 30 °C for
20 min in incubation solution containing 0.05% (w/v) collagenase,
kidney slices were stored at 4 °C. Single MTAL were microdissected
under stereomicroscopic control in oxygenated (95% O2,
5% CO2) incubation solution.
Preparation of Suspensions of MTALs--
The two kidneys were
perfused with ice-cold incubation solution without collagenase. The
inner stripes of the outer medulla were excised and minced on ice, and
fragments of medullary tubules were obtained by gentle pression through
nylon filters with pore size decreasing from 150 to 100 µm. After
centrifugation, the pellet was resuspended in ice-cold oxygenated (95%
O2, 5% CO2) incubation solution. As controlled
under stereomicroscope, MTALs account for about 90% of the tubule
fragments in this preparation. Therefore, it will be referred to as
MTAL suspension.
Immunoblots--
After preincubation in isotonic incubation
solution, MTALs were incubated in isotonic or hypertonic incubation
solutions with or without addition of drugs. Incubation was stopped by
cooling and centrifugation before addition of ice-cold lysis buffer
containing 20 mM Tris-HCl, 2 mM EGTA, 2 mM EDTA, 30 mM NaF, 30 mM
Na4O7P2, 2 mM
Na3VO4, 1 mM AEBSF, 10 µg/ml
leupeptin, 4 µg/ml aprotinin, 1% Triton X-100, pH 7.45. After
measurement of protein content by the BCA protein assay (Pierce), equal
amounts of protein were separated by 10% SDS-PAGE and transferred to a
polyvinylidene difluoride membrane (Immobilion-P, Millipore). For each
experiment, equal transfer of proteins was verified by Ponceau Red
staining. Membranes were then blocked in Tris-buffered saline (50 mM Tris, 150 mM NaCl) with 0.2% (v/v) Nonidet
P-40 (TBS-Nonidet P-40) and 5% (w/v) nonfat dry milk for 1 h at
room temperature and then incubated for 2 h at room temperature
with first antibody diluted in TBS-Nonidet P-40 with 5% of milk.
Dilutions (v/v) were: 1/1000 for anti-ERK-P and anti-p38-P kinase (New
England Biolabs, Beverly, MA); 1/200 for anti-JNK-P; and 1/1000 for
anti-ERK and anti-p38 kinase (Santa Cruz Biotechnology, Santa Cruz,
CA). The membranes were then washed three times and incubated for
1 h at room temperature with anti-rabbit IgG antibodies coupled to
horseradish peroxidase (Transduction Laboratories, Lexington, KY) at
dilution 1/10,000 (v/v) in TBS-Nonidet P-40 with 5% milk. After three
washes in TBS-Nonidet P-40, immunoreactivity was detected by
chemiluminescence using the Super Signal Substrate method (Pierce).
Results were quantitated under conditions of linearity by integration
of the density of the total area of each band using a video
densitometer and the ImageQuant software (Molecular Dynamics). Results
are expressed as a percentage of the control optical density (isotonic medium) and are means ± S.E.
Preliminary experiments using ERK activator (phorbol 12,13-dibutyrate)
and JNK/p38 kinase activator (anisomycine) have confirmed the
specificity of the anti-phospho-MAP kinase antibodies (data not shown).
Determination of MTAL Cellular Volume--
A pool of 3 isolated
MTALs was transferred into the concavity of a bacteriological slide
coated with dried BSA. After preincubation at 37 °C in isotonic
incubation solution, tubules were incubated in isotonic or hypertonic
incubation solutions with or without addition of drugs. MTALs were
visualized with an inverted microscope and photographies of the same
tubules were taken at the end of the preincubation period and after
incubation. The MTAL volume was calculated from the measured length and
diameter of the tubules (magnification, ×1000). Since in non-perfused
tubules, the lumen is collapsed, we assumed that MTAL volume
measurement is an appropriate estimate of the MTAL cellular volume.
Results are expressed as a percentage of the control volume (end of the
preincubation period) and are means ± S.E.
Statistical Analysis--
Differences between two groups were
evaluated by Mann-Whitney U test; differences between more
groups were evaluated with Kruskall-Wallis test. p values
less than 0.05 were considered significant.
 |
RESULTS |
Hypertonic NaCl and Sucrose but Not Urea Increased ERK and p38
Kinase Phosphorylation in MTAL Cells--
MTAL suspensions, as well as
microdissected MTALs were incubated for 15 min at 37 °C in isotonic
or hypertonic incubation solution. Osmolarity was raised up to 600 mosmol/liter by addition of hypertonic NaCl or sucrose. Fig.
1 shows that hypertonic NaCl and sucrose
increased the phosphorylation level of ERK (as percentage of
control ± S.E.; NaCl: 295 ± 60%, p < 0.005; sucrose: 975 ± 327%, p < 0.005) and p38
kinase (NaCl: 317 ± 32%, p < 0.01; sucrose: 320 ± 124%, p < 0.005) in microdissected MTALs
(Fig. 1A) as well as in MTAL suspensions (Figs. 1,
C and D). As depicted in Fig. 1B, the
total amounts of ERK and p38 kinase were identical in both
preparations, suspensions or microdissected MTALs (Fig. 1, A
and C). Thus all subsequent experiments were performed
in MTAL suspensions.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of hyperosmolarity on the
phosphorylation level of ERK and p38 kinase in suspensions of MTALs and
microdissected MTALs. Microdissected and suspensions of
mechanically dissociated MTALs were incubated for 15 min at 37 °C
under control conditions (C; 300 mosmol/liter) or after
addition of either NaCl (N) or sucrose (S) up to
600 mosmol/liter. After cell lysis, proteins were separated by 10%
SDS-PAGE and transferred on a polyvinylidene difluoride membrane, and
MAP kinases were detected by immunoblot. A, representative
immunoblots with phospho-specific antibodies showing the
phosphorylation level of ERK and p38 kinase in microdissected MTALs.
B, representative immunoblots with anti-ERK2 and anti-p38
kinase antibodies showing the total amounts of ERK and p38 kinase in
suspensions of mechanically dissociated MTALs. C, immunoblot
of the membrane shown in B with phospho-specific antibodies showing the
phosphorylation level of ERK and p38 kinase. D,
densitometric quantitation of the phosphorylation level of MAP kinases
in MTALs suspensions (shown in C). Results are expressed as
a percentage of control and are means ± S.E. from five to six
independent experiments (**, p < 0.01; ***,
p < 0.005).
|
|
Dose Dependence of MAP Kinase Phosphorylation--
The dose
dependence of the effect of extracellular osmolarity on MAP kinases
phosphorylation was determined by a 15-min incubation of MTAL
suspension in solution with osmolarity increasing from 300 to 700 mosmol/liter by addition of NaCl, sucrose, or urea.
As shown in Fig. 2, NaCl-induced
extracellular hypertonicity produced a dose-dependent
increase of the phosphorylation level of ERK. This effect reached a
maximum at 600 mosmol/liter (as percentage of control ± S.E.:
295 ± 60%, p < 0.005). Similarly, the
phosphorylation level of p38 kinase was maximally increased at 500 mosmol/liter NaCl (334 ± 45%, p < 0.001). By
contrast, the phosphorylation level of JNK was not altered by
hypertonic NaCl.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of increasing extracellular osmolarity
by addition of NaCl on the phosphorylation level of ERK, JNK, and p38
kinase. Suspensions of MTAL were incubated for 15 min at 37 °C
in media with osmolarity increasing from 300 to 700 mosmol/liter by
addition of NaCl. Phosphorylated MAP kinases were detected by
immunoblot with phosphospecific antibodies. A,
representative immunoblot showing the phosphorylation level of ERK,
JNK, and p38 kinase in response to increasing extracellular
osmolarities. B, densitometric quantitation of the effect of
extracellular osmolarity on the phosphorylation level of ERK
(filled squares), JNK (filled
triangles), and p38 kinase (filled
circles). Results are expressed as a percentage of control
and are means ± S.E. from six independent experiments (*,
p < 0.05; **, p < 0.01; ***,
p < 0.005).
|
|
Hypertonic sucrose induced a dose-dependent increase in ERK
phosphorylation with a maximum at 600 mosmol/liter (975 ± 327%, p < 0.005) and in p38 kinase phosphorylation with a
maximum at 500 mosmol/liter (320 ± 99%, p < 0.005), respectively. In contrast with NaCl, hypertonic sucrose
increased JNK phosphorylation with a maximum at 600 mosmol/liter
(273 ± 59%, p < 0.005) (Fig.
3).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of increasing osmolarity by sucrose on
the phosphorylation level of ERK, JNK, and p38 kinase. Suspensions
of MTAL were submitted to the procedure described in Fig. 2, except
that osmolarity was increased by addition of sucrose instead of NaCl.
A, representative immunoblot showing the phosphorylation
level of ERK, JNK, and p38 kinase in response to increasing
extracellular osmolarities. B, densitometric quantitation of
the effect of extracellular osmolarity on the phosphorylation level of
ERK (filled squares), JNK (filled
triangles), and p38 kinase (filled
circles). Results are expressed as a percentage of control
and are means ± S.E. from five independent experiments (*,
p < 0.05; **, p < 0.01; ***,
p < 0.005).
|
|
Finally, hypertonic urea did not significantly alter the
phosphorylation level of MAP kinases (Fig.
4).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of increasing osmolarity by urea on
the phosphorylation level of ERK, JNK, and p38 kinase. Suspensions
of MTAL were submitted to the procedure described in Fig. 2, except
that osmolarity was increased by addition of urea instead of NaCl.
A, representative immunoblot showing the phosphorylation
level of ERK, JNK, and p38 kinase in response to increasing
extracellular osmolarities. B, densitometric quantitation of
the effect of extracellular osmolarity on the phosphorylation level of
ERK (filled squares), JNK (filled
triangles), and p38 kinase (filled
circles). Results are expressed as a percentage of control
and are means ± S.E. from two independent experiments.
|
|
Time Dependence of MAP Kinase Phosphorylation--
To determine
the time course of the effect of extracellular osmolarity on
phosphorylation of MAP kinases, MTAL suspensions were incubated for a
total period of 30 min at 37 °C including adjunction (experimental)
or not (control) of a prewarmed hypertonic (NaCl or sucrose up to 600 mosmol/liter) incubation solution for periods varying from 1 to 30 min.
Exposure to hypertonic NaCl solution produced an increase in the
phosphorylation level of ERK which peaked at 3 min (as percentage of
control ± S.E.: 271 ± 61%, p < 0.005) and
then progressively decreased to the control level after 30 min (Fig.
5). Similarly, phosphorylation of p38 kinase increased progressively during the first 5 min of incubation to
reach a maximum of 404 ± 116% of the control level
(p < 0.005). Phosphorylation of p38 kinase then
gradually decreased and reached a plateau of 183 ± 84% of the
control value after 30 min of incubation. The phosphorylation level of
JNK was not significantly altered during the 30-min incubation with
hypertonic NaCl.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of incubation time with hypertonic
NaCl on the phosphorylation level of ERK, JNK, and p38 kinase.
Suspensions of MTAL were incubated for 30 min at 37 °C. Controls
were incubated in isotonic medium (300 mosmol/liter), and the other
samples were incubated in a medium containing 600 mosmol/liter NaCl for
1-30 min. Phosphorylated MAP kinases were detected by immunoblot with
phosphospecific antibodies. A, representative immunoblot
showing the phosphorylation level of ERK, JNK, and p38 kinase in
response to 600 mosmol/liter NaCl for various times. B,
densitometric quantitation of the effect of extracellular osmolarity on
the phosphorylation level of ERK (filled
squares), JNK (filled triangles), and
p38 kinase (filled circles). Results were
expressed as a percentage of the control and are means ± S.E.
from five independent experiments (*, p < 0.05; **,
p < 0.01; ***, p < 0.005).
|
|
With hypertonic sucrose, the ERK phosphorylation increased
progressively during the incubation and reached a maximum of 1034 ± 397% of the control level (p < 0.005) at 5 min
(Fig. 6). Phosphorylation of p38 kinase
increased within the same time course and reached a maximum of 609 ± 237% of the control level (p < 0.005). By contrast with NaCl, we did not observe a progressive decrease in phosphorylation level of both ERK and p38 kinase, which was sustained for 30 min. The
phosphorylation level of JNK increased progressively in response to
hypertonic sucrose and reached a maximum after 30 min of incubation (as
percentage of control ± S.E.: 251 ± 68%, p < 0.05).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of incubation time with hypertonic
sucrose on the phosphorylation level of ERK, JNK, and p38 kinase.
Suspensions of MTAL were submitted to the procedure described in Fig.
5, except that osmolarity was increased by addition of sucrose instead
of NaCl. A, representative immunoblot showing the
phosphorylation level of ERK, JNK, and p38 kinase in response to 600 mosmol/liter by addition of sucrose for various times. B,
densitometric quantitation of the effect of extracellular osmolarity on
the phosphorylation level of ERK (filled
squares), JNK (filled triangles), and
p38 kinase (filled circles). Results were
expressed as a percentage of the control and are means ± S.E.
from five independent experiments (*, p < 0.05; **,
p < 0.01; ***, p < 0.005).
|
|
Hypertonic NaCl and Sucrose but Not Urea Decreased the Volume of
Single MTALs in a Dose- and Time-dependent Manner--
The
effects of extracellular hyperosmolarity on the MTAL cellular volume
were determined by the following experiments. After a 15-min
preincubation period at 37 °C, single MTALs were incubated for 15 min at 37 °C in iso-osmotic or hyperosmotic incubation solutions.
Osmolarity was raised up to 600 mosmol/liter by addition of hypertonic
NaCl, sucrose, or urea. Fig. 7 shows that
hypertonic NaCl and sucrose decreased the MTAL cellular volume. In
contrast, urea did not alter MTAL cellular volume.

View larger version (80K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of hyperosmolarity on the cellular
volume of single MTALs. Microdissected single MTALs were incubated
for 10 min at 37 °C either under isotonic conditions (C;
300 mosmol/liter) or after addition of NaCl (N), sucrose
(S), and urea (U) up to 600 mosmol/liter. Tubules
were visualized with an inverted microscope, and photographs were taken
before (upper photographs) and after
(lower photographs) incubation. A-D,
representative photographs showing the effect of incubation in isotonic
or hypertonic media on cellular volume. E, quantitation of
the effect of extracellular osmolarity on cellular volume. Results are
expressed as a percentage of control (initial volume) and are
means ± S.E. from four to six independent experiments (**,
p < 0.01; ***, p < 0.005).
|
|
As shown in Fig. 8A,
increasing osmolarity with hypertonic NaCl decreased MTAL cellular
volume in a dose-dependent manner with a maximal reduction
of 30.64 ± 2.01% of the initial volume (p < 0.001) (Fig. 8A). Similarly, sucrose solution induced a
dose-dependent decrease in MTAL cellular volume reaching a
34.92 ± 3.04% reduction from the initial volume
(p < 0.05). Over the range of extracellular osmolarity
studied, urea did not alter MTAL cellular volume.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 8.
Dose dependence and time course of the effect
of extracellular hyperosmolarity on the cellular volume of single
MTALs. A, single microdissected MTALs were incubated
for 10 min at 37 °C in media with increasing osmolarities (300-700
mosmol/liter) by addition of NaCl (filled
squares), sucrose (filled triangles),
or urea (filled circles). B, single
microdissected MTALs were incubated for 30 min at 37 °C. Controls
were incubated in isotonic medium (300 mosmol/liter), and the other
samples were incubated in a medium containing 600 mosmol/liter NaCl
(filled squares) or sucrose (filled
triangles) for 1 to 30 min. Cellular volume was determined
as described in legend of Fig. 7. Results are expressed as a percentage
of control (initial volume) and are means ± S.E. from four to six
independent experiments (*, p < 0.05; **,
p < 0.01; ***, p < 0.005; #,
p < 0.001).
|
|
For time-course experiments, single MTALs were incubated for a total
period of 30 min at 37 °C including adjunction (experimental) or not
(control) of a prewarmed hypertonic (NaCl or sucrose up to 600 mosm/liter) incubation solution for periods varying from 1 to 30 min.
Fig. 8B shows the time-dependent change in MTAL
cellular volume. Increasing incubation time with hypertonic NaCl
decreased MTAL cellular volume with a maximal decrease to 68.98 ± 2.21% of the initial volume (p < 0.001) after 10 min
of incubation. Increasing incubation time with hyperosmotic NaCl was
associated with a progressive recovery of tubule volume that peaked
after 30 min of incubation (89.14 ± 2.24%, p < 0.01). Incubation with hypertonic sucrose gave similar results,
although the decrease in MTAL cellular volume was slightly more
pronounced than with NaCl, reaching 65.47 ± 0.58% of the initial
volume (p < 0.001) after 5 min and it was sustained
for 15 min. After 30 min of incubation with hypertonic solution, a
partial recovery of initial MTAL cellular volume was observed to a
lesser extent than with NaCl (81.81 ± 5.94%, p < 0.05).
The Phosphorylation Level of ERK/p38 Kinase Correlated with the
MTAL Cellular Volume--
To assess the possibility of a relationship
between the phosphorylation level of ERK/p38 kinase and the tubule
volume, the changes in phosphorylation level of ERK and p38 kinase were
plotted as a function of the variations in MTAL cellular volume.
Fig. 9A, drawn from the data
presented in Figs. 2, 3, 5, 6, and 8, shows the linear relationship
existing between the phosphorylation level of ERK and the decrease in
MTAL cellular volume (r = 0.75). This linear
relationship (r = 0.88) was even stronger for p38 kinase (Fig. 9B).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 9.
Correlations between the ERK/p38 kinase
phosphorylation and the modifications of the MTAL cellular volume.
The variations in phosphorylation level of ERK (A) and p38
kinase (B) determined in suspensions of MTAL were plotted as
a function of the modifications in cellular volume of single MTALs
incubated under the same conditions. Values are expressed as a
percentage of control ± S.E.
|
|
Change in Cell Volume Rather than in Osmolarity Was Responsible for
the Alteration in Phosphorylation Level of ERK and p38 Kinase--
The
following experiments were designed to analyze separately the effects
of intracellular hyperosmolarity and cell shrinkage on the increase in
phosphorylation level of ERK and p38 kinase.
To induce intracellular hypertonicity without cell volume variation,
suspensions or single MTALs were incubated for 9 min in the presence of
10 4 M nystatin (Sigma) in ice-cold isotonic
incubation solution (300 mosmol/liter) in which NaCl was substituted
for KCl. After three washes in ice-cold isotonic KCl incubation
solution, tubules were incubated first in ice-cold hypertonic KCl
medium (600 mosmol/liter) for 5 min and then in prewarmed (37 °C)
hypertonic NaCl medium (600 mosmol/liter) for 5 additional min. Control
experiments have shown that MTAL cellular volume was 94.6 ± 2.1%
of its initial value after this procedure. Fig.
10 (A and B)
shows that when the MTAL cellular volume decreased, hypertonicity
increased the phosphorylation level of ERK and p38 kinase by 269 ± 37% (p < 0.005) and by 179 ± 32%
(p < 0.05), respectively. In contrast, when the MTAL
cellular volume was maintained constant, intracellular hypertonicity
did not alter the phosphorylation level of ERK and p38 kinase.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 10.
Respective role of hyperosmolarity and
decreased MTAL cellular volume on the activation of ERK and p38
kinase. Suspensions of MTAL were incubated for 5 min in isotonic
(300 mosmol/liter) or hypertonic (600 mosmol/liter) media under
conditions where the MTAL cellular volume was kept constant (=) or
decreased (downward arrow), as described under
"Results." A representative immunoblot shows the phosphorylation
level of ERK (A) and p38 kinase (B) according to
extracellular osmolarity and cellular volume. The effects of
extracellular osmolarity and cellular volume variations on the
phosphorylation level of ERK (A) and p38 kinase
(B) were quantitated by densitometry. Results are expressed
as a percentage of control and are means ± S.E. from six
independent experiments (*, p < 0.05; **,
p < 0.01; ***, p < 0.005; #,
p < 0.001).
|
|
A decrease in MTAL cellular volume at constant intracellular osmolality
was obtained by 20-min incubation of tubules at 37 °C with
10 4 M nystatin in isotonic incubation
solution in which NaCl was substituted for sucrose. This isotonic cell
shrinkage was reversed by three washes in isotonic sucrose incubation
solution without nystatin followed by a 5-min incubation at 37 °C in
isotonic NaCl incubation solution. Control experiments have shown that
MTAL cellular volume was 71.1 ± 0.2% of its initial value after
incubation with isotonic sucrose plus nystatin, and returned to
102.1 ± 2.0% of its initial value after removal of nystatin and
incubation with isotonic NaCl. As depicted in Fig. 10 (A and
B), decreasing MTAL cellular volume under isotonic condition
increased the phosphorylation level of ERK and p38 kinase by 239 ± 41% (p < 0.001) and 166 ± 20%
(p < 0.05), respectively. This effect was reversible
upon recovery of initial cellular volume.
p38 Kinase Was Involved in the Regulatory Cell Volume Increase
(RVI) of MTAL--
The following experiments were performed to assess
the possible role of MAP kinase activation in the RVI of MTAL. After a 15-min preincubation in isotonic NaCl incubation solution with or
without 8 × 10 5 M SB203580 (Calbiochem,
San Diego, CA), a specific inhibitor of p38 kinase, single MTALs were
incubated for 5-30 min with hypertonic NaCl (600 mosmol/liter).
Preincubation of tubules with SB203580 did not alter the MTAL cellular
volume under isotonic condition. In contrast, SB203580 inhibited the
MTAL cellular volume recovery process observed after 30 min of
incubation under hypertonic condition (Fig.
11). In contrast, 4 × 10 4 M PD98059 (Calbiochem), a specific
inhibitor of ERK pathway, did not alter MTAL cellular volume under
isotonic or hypertonic conditions, indicating that ERK is not necessary
for cell volume control (data not shown). Control experiments have
shown that this concentration of PD98059 prevented the increase in
phosphorylation of ERK in response to 600 mosmol/liter extracellular
osmolarity.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 11.
Role of p38 kinase in the regulatory cell
volume increase of single MTALs. Single microdissected MTALs were
incubated for 30 min at 37 °C after a 15-min preincubation with
(circles) or without (squares) 8 × 10 5 M SB203580, a specific p38 kinase
inhibitor. Controls were incubated with an osmolarity of 300 mosmol/liter (open symbols), and the other
samples were incubated with 600 mosmol/liter NaCl for 5-30 min
(filled symbols). A, representative
photographies showing the effect of SB203580 on MTAL cellular volume
before (upper photographs) and after 30 min of
incubation at 37 °C (lower photographs) in
isotonic (left) or hypertonic (right) media.
B, quantitation of the effect of extracellular
hyperosmolarity and SB203580 on MTAL cellular volume. Results are
expressed as a percentage of control and are means ± S.E. from
seven independent experiments (*, p < 0.05).
|
|
 |
DISCUSSION |
The present study shows that cell shrinkage induced by
extracellular hypertonicity activates MAP kinases in rat MTAL. In
addition, our results indicate that, among the MAP kinases, p38 kinase
appears to play a major role in the early cell protective response to extracellular hypertonicity, i.e. the RVI.
Extracellular hypertonicity has been shown to activate MAP kinases in
various animal cell lines (5), including MDCK cells (26, 27, 31) that
share some properties with mammalian distal nephron cells and mIMCD
cells (8, 29, 32). Our study, taken with the results of Watts et
al. (30), extends this finding to native rat MTAL cells, which are
exposed to extracellular osmolarities from 300 to 600 mosmol/liter
under water diuresis and antidiuresis, respectively (1). In the present
study, the level of phosphorylation of MAP kinases was taken as an
index of their activation since only phosphorylated MAP kinases are
active (5) and the increase in phosphorylation parallels the activity
of MAP kinases in MTAL cells (30). Our results, taken together with a
recent study showing that water restriction activates MAP kinases in
the rat renal inner medulla (33), support the physiological relevance of the activation of MAP kinases by extracellular hypertonicity.
The major role of MTAL cell shrinkage in the hypertonicity-induced MAP
kinases activation is supported by the following observations. 1)
Hypertonic urea, which did not alter cellular volume, did not activate
MAP kinases; 2) hypertonic sucrose, which induced a larger decrease in
cellular volume, was a more powerful activator of ERK and p38 kinases
than hypertonic NaCl; 3) cellular volume was inversely correlated with
the activation level of ERK and p38 kinases; 4) increased intracellular
osmolarity without alteration in cellular volume did not activate ERK
and p38 kinase; and 5) cell shrinkage under isotonic conditions was
associated with an activation of ERK and p38 kinase, which was
reversible upon return to the initial cell volume. These results
strongly suggest that cell shrinkage activates the MAP kinases in rat
MTAL cells. A role for cell volume variations in the regulation of
cellular signaling pathways has already been demonstrated in human
polymorphonuclear cells (34).
Since hyperosmolarity activates MAP kinases through changes in cellular
volume, the hypothesis that components of the cytoskeleton may be the
primary sensor should be considered. Moreover, extracellular hypertonicity drives water movement outside the cells leading to an
increase in cytoplasmic concentration of macromolecules, which could
play the role of volume sensor (2). Finally, aggregation of growth
factor and cytokine receptors leading to their ligand-independent activation could participate to the activation of MAP kinases by
hypertonicity via membrane-based sensors (18). Indeed, hypertonicity increases tyrosine phosphorylation of cellular proteins in human polymorphonuclear cells (34) and in Chinese hamster ovary cells (35)
and the activation of ERK and p38 kinase is tyrosine
kinase-dependent in rat MTAL cells (30).
Whereas both MTAL and IMCD cells are exposed to extracellular
hypertonicity, comparison of the activation pattern of MAP kinases reveals a cellular specificity. In agreement with Watts et
al. (30), our study shows that in MTAL cells, JNK is not activated by hypertonic NaCl, in contrast with the marked activation of JNK by
hypertonic NaCl in mIMCD cells (VC52, VC18). Nevertheless, hypertonic
sucrose stimulated JNK by about 2-fold in MTAL cells. However, JNK
activation was considerably lower than stimulation of both ERK (about
10-fold) and p38 kinase (about 4-fold). This higher activation level of
MAP kinases might be related to the more pronounced cell shrinkage
induced by hypertonic sucrose as compared with hypertonic NaCl. In MTAL
cells, cell shrinkage may induce a sequential activation of MAP kinases
pathway, with a more sensitive response of ERK and p38 kinase pathways.
The RVI is an essential mechanism of cellular protection against
osmotic stress. After the initial cell shrinkage, MTAL cells exhibit a
RVI response that involves the activation of ion transporters (3). This
process drives sodium influx coupled to secondary water movements into
the cells and allows the partial recovery of the initial cell volume
(2). Our results confirm that MTAL cells undergo RVI after an
hypertonic challenge (3) with NaCl and sucrose, and show that p38
kinase activation is required for this process, while ERK pathway does
not appear to play a role. Whether p38 kinase activates ion
transporters through direct phosphorylation or involves intermediate
steps remains to be determined. Among them, one can postulate a role
for a p38-dependent cytoskeletal remodeling (22).
In conclusion, we have shown that, in rat MTAL cells, hypertonic
extracellular medium activates ERK and p38 kinase and in a lesser
extent JNK. This activation was not the direct consequence of an
increase in intracellular osmolarity, but was mediated by cell
shrinkage. In addition, this study demonstrates that activation of p38
kinase is essential in the regulatory cell volume increase process, a
cell protection mechanism against the physiological hyperosmolarity of
the rat kidney medulla.
 |
ACKNOWLEDGEMENT |
We thank Dr. S. Gonin for critical reading of
the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by Grant 31-50-643.97 from
the Swiss National Science Research Foundation (to H. F. and
E. F.) and by a grant from the Société
Académique de Genève (to E. F.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 41-22-382-38-37;
Fax: 41-22-347-59-79; E-mail: feraille@cmu.unige.ch.
 |
ABBREVIATIONS |
The abbreviations used are:
MTAL, medullary
thick ascending limb of Henle;
AEBSF, [4-(2-aminoethyl)-benzenesulfonylfluoride)];
BSA, bovine serum
albumin;
ERK, extracellular signal-regulated kinase;
JNK, c-Jun
NH2-terminal kinase;
PAGE, polyacrylamide gel
electrophoresis;
RVI, regulatory volume increase;
TBS, Tris-buffered
saline;
MAP, mitogen-activated protein;
MAPK, mitogen-activated protein
kinase.
 |
REFERENCES |
| 1.
|
Knepper, M. A.,
and Rector, F. C., Jr.
(1996)
in
The Kidney
(Brenner, B. M., ed), 5th Ed.
, pp. 532-570, W. B. Saunders Co., Philadelphia
|
| 2.
|
Parker, J. C.
(1993)
Am. J. Physiol.
265,
C1191-C1200[Abstract/Free Full Text]
|
| 3.
|
Sun, A. M.,
Saltzberg, S. N.,
Kikeri, D.,
and Hebert, S. C.
(1990)
Kidney Int.
38,
1019-1029[Medline]
[Order article via Infotrieve]
|
| 4.
|
Burg, M. B.
(1995)
Am. J. Physiol.
268,
F983-F996[Abstract/Free Full Text]
|
| 5.
|
Widmann, C.,
Gibson, S.,
Jarpe, M. B.,
and Johnson, G. L.
(1999)
Physiol. Rev.
79,
143-180[Abstract/Free Full Text]
|
| 6.
|
Wu, J.,
Dent, P.,
Jelinek, T.,
Wolfman, A.,
Weber, M. J.,
and Sturgill, T. W.
(1993)
Science
262,
1065-1072[Abstract/Free Full Text]
|
| 7.
|
Graves, L. M.,
Bornfeldt, K. E.,
Raines, E. W.,
Potts, B. C.,
MacDonald, S. G.,
Ross, R.,
and Krebs, E. G.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
10300-10304[Abstract/Free Full Text]
|
| 8.
|
Ferby, I. M.,
Waga, I.,
Sakanaka, C.,
Kume, K.,
and Shimizu, T.
(1994)
J. Biol. Chem.
269,
30485-30488[Abstract/Free Full Text]
|
| 9.
|
Morino, N.,
Mimura, T.,
Hamasaki, K.,
Tobe, K.,
Ueki, K.,
Kikuchi, K.,
Takehara, K.,
Kadowaki, T.,
Yazaki, Y.,
and Nojima, Y.
(1995)
J. Biol. Chem.
270,
269-273[Abstract/Free Full Text]
|
| 10.
|
Flordellis, C. S.,
Berguerand, M.,
Gouache, P.,
Barbu, V.,
Gavras, H.,
Handy, D. E.,
Béréziat, G.,
and Masliah, J.
(1995)
J. Biol. Chem.
270,
3491-3494[Abstract/Free Full Text]
|
| 11.
|
Crespo, P.,
Xu, N.,
Simmonds, W. S.,
and Gutkind, J. S.
(1994)
Nature
369,
418-420[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Liao, D.-F.,
Monia, B.,
Dean, N.,
and Berk, B. C.
(1997)
J. Biol. Chem.
272,
6146-6150[Abstract/Free Full Text]
|
| 13.
|
Ip, T.,
and Davis, R. J.
(1998)
Curr. Opin. Cell Biol.
10,
205-219[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Freshney, N. W.,
Rawlinson, L.,
Guesdon, F.,
Jones, E.,
Cowley, S.,
Hsuan, J.,
and Saklatvala, J.
(1994)
Cell
78,
1039-1049[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Sluss, H. K.,
Barrett, T.,
Dérijard, B.,
and Davis, R. J.
(1994)
Mol. Cell. Biol.
14,
8376-8384[Abstract/Free Full Text]
|
| 16.
|
Matsuda, S.,
Kawasaki, H.,
Moriguchi, T.,
Gotoh, Y.,
and Nishida, E.
(1995)
J. Biol. Chem.
270,
12781-12786[Abstract/Free Full Text]
|
| 17.
|
Chen, Y.-R.,
Wang, X.,
Templeton, D.,
Davis, R. J.,
and Tan, T.-H.
(1996)
J. Biol. Chem.
271,
31929-31936[Abstract/Free Full Text]
|
| 18.
|
Rosette, C.,
and Karin, M.
(1996)
Science
274,
1194-1197[Abstract/Free Full Text]
|
| 19.
|
Eldar-Finkelman, H.,
Seger, R.,
Vandenheede, R.,
and Krebs, E. G.
(1995)
J. Biol. Chem.
270,
987-990[Abstract/Free Full Text]
|
| 20.
|
Chang, P.-Y.,
Le Marchand-Brustel, Y.,
Cheatham, L. A.,
and Moller, D. E.
(1995)
J. Biol. Chem.
270,
29928-29935[Abstract/Free Full Text]
|
| 21.
|
Liu, H.,
and Maurice, D. H.
(1999)
J. Biol. Chem.
274,
10557-10565[Abstract/Free Full Text]
|
| 22.
|
Huot, J.,
Houle, F.,
Rousseau, S.,
Deschesnes, R. G.,
Shah, G. M.,
and Landry, J.
(1998)
J. Cell Biol.
143,
1361-1373[Abstract/Free Full Text]
|
| 23.
|
Matsumoto, T.,
Yokote, K.,
Tamura, K.,
Takemoto, M.,
Ueno, H.,
Saito, Y.,
and Mori, S.
(1999)
J. Biol. Chem.
274,
13954-13960[Abstract/Free Full Text]
|
| 24.
|
Sweeney, G.,
Somwar, R.,
Ramlal, T.,
Volchuk, A.,
Ueyama, A.,
and Klip, A.
(1999)
J. Biol. Chem.
274,
10071-10078[Abstract/Free Full Text]
|
| 25.
|
Galcheva-Gargova, Z.,
Dérijard, B.,
Wu, I.-H.,
and Davis, R. J.
(1994)
Science
265,
806-811[Abstract/Free Full Text]
|
| 26.
|
Itoh, T.,
Yamauchi, A.,
Miyai, A.,
Yokoyama, K.,
Kamada, T.,
Ueda, N.,
and Fujiwara, Y.
(1994)
J. Clin. Invest.
93,
2387-2392
|
| 27.
|
Terada, Y.,
Tomita, K.,
Homma, M. K.,
Nonoguchi, H.,
Yang, T.,
Yamada, T.,
Yuasa, Y.,
Krebs, E. G.,
Sasaki, S.,
and Marumo, F.
(1994)
J. Biol. Chem.
269,
31296-31301[Abstract/Free Full Text]
|
| 28.
|
Zhang, Z.,
and Cohen, D. M.
(1996)
Am. J. Physiol.
271,
F1234-F1238[Abstract/Free Full Text]
|
| 29.
|
Berl, T.,
Siriwardana, G.,
Ao, L.,
Butterfield, L. M.,
and Heasley, L. E.
(1997)
Am. J. Physiol.
272,
F305-F311[Abstract/Free Full Text]
|
| 30.
|
Watts, B. A. I.,
Di Mari, J. F.,
Davis, R. J.,
and Good, D. W.
(1998)
Am. J. Physiol.
275,
F478-F486[Abstract/Free Full Text]
|
| 31.
|
Sheikh-Hamad, D.,
Di Mari, J.,
Suki, W. N.,
Safirstein, R.,
Watts, B. A., III.,
and Rouse, D.
(1998)
J. Biol. Chem.
273,
1832-1837[Abstract/Free Full Text]
|
| 32.
|
Kültz, D.,
Madhany, S.,
and Burg, M. B.
(1998)
J. Biol. Chem.
273,
13645-13651[Abstract/Free Full Text]
|
| 33.
|
Wojtaszek, P. A.,
Heasley, L. E.,
and Berl, T.
(1998)
J. Clin. Invest.
102,
1874-1881[Medline]
[Order article via Infotrieve]
|
| 34.
|
Krump, E.,
Nikitas, K.,
and Grinstein, S.
(1997)
J. Biol. Chem.
272,
17303-17311[Abstract/Free Full Text]
|
| 35.
|
Kapus, A.,
Szaszi, K.,
Sun, J.,
Rizoli, S.,
and Rotstein, O. D.
(1999)
J. Biol. Chem.
274,
8093-8102[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
U. Hasler
Controlled aquaporin-2 expression in the hypertonic environment
Am J Physiol Cell Physiol,
April 1, 2009;
296(4):
C641 - C653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. K. Hoffmann, I. H. Lambert, and S. F. Pedersen
Physiology of Cell Volume Regulation in Vertebrates
Physiol Rev,
January 1, 2009;
89(1):
193 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Inagaki, E. Omori, J.-Y. Kim, Y. Komatsu, G. Scott, M. K. Ray, G. Yamada, K. Matsumoto, Y. Mishina, and J. Ninomiya-Tsuji
TAK1-binding Protein 1, TAB1, Mediates Osmotic Stress-induced TAK1 Activation but Is Dispensable for TAK1-mediated Cytokine Signaling
J. Biol. Chem.,
November 28, 2008;
283(48):
33080 - 33086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Hasler, P. Nunes, R. Bouley, H. A. J. Lu, T. Matsuzaki, and D. Brown
Acute Hypertonicity Alters Aquaporin-2 Trafficking and Induces a MAPK-dependent Accumulation at the Plasma Membrane of Renal Epithelial Cells
J. Biol. Chem.,
September 26, 2008;
283(39):
26643 - 26661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-B. Nielsen, S. T. Christensen, and E. K. Hoffmann
Effects of osmotic stress on the activity of MAPKs and PDGFR-{beta}-mediated signal transduction in NIH-3T3 fibroblasts
Am J Physiol Cell Physiol,
April 1, 2008;
294(4):
C1046 - C1055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Burg, J. D. Ferraris, and N. I. Dmitrieva
Cellular Response to Hyperosmotic Stresses
Physiol Rev,
October 1, 2007;
87(4):
1441 - 1474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. K. Hoffmann and S. F. Pedersen
Shrinkage insensitivity of NKCC1 in myosin II-depleted cytoplasts from Ehrlich ascites tumor cells
Am J Physiol Cell Physiol,
May 1, 2007;
292(5):
C1854 - C1866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xu, R. T. Worrell, H. C. Li, S. L. Barone, S. Petrovic, H. Amlal, and M. Soleimani
Chloride/Bicarbonate Exchanger SLC26A7 Is Localized in Endosomes in Medullary Collecting Duct Cells and Is Targeted to the Basolateral Membrane in Hypertonicity and Potassium Depletion
J. Am. Soc. Nephrol.,
April 1, 2006;
17(4):
956 - 967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Friis, C. R. Friborg, L. Schneider, M.-B. Nielsen, I. H. Lambert, S. T. Christensen, and E. K. Hoffmann
Cell shrinkage as a signal to apoptosis in NIH 3T3 fibroblasts
J. Physiol.,
September 1, 2005;
567(2):
427 - 443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Marshall, C. G. Ossum, and E. K. Hoffmann
Hypotonic shock mediation by p38 MAPK, JNK, PKC, FAK, OSR1 and SPAK in osmosensing chloride secreting cells of killifish opercular epithelium
J. Exp. Biol.,
March 15, 2005;
208(6):
1063 - 1077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhao, R. Hyde, and H. S Hundal
Signalling mechanisms underlying the rapid and additive stimulation of NKCC activity by insulin and hypertonicity in rat L6 skeletal muscle cells
J. Physiol.,
October 1, 2004;
560(1):
123 - 136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Lang, S. Myssina, P. A. Lang, V. Tanneur, D. S. Kempe, A. F. Mack, S. M. Huber, T. Wieder, F. Lang, and C. Duranton
Inhibition of erythrocyte phosphatidylserine exposure by urea and Cl-
Am J Physiol Renal Physiol,
June 1, 2004;
286(6):
F1046 - F1053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Myssina, S. M. Huber, C. Birka, P. A. Lang, K. S. Lang, B. Friedrich, T. Risler, T. Wieder, and F. Lang
Inhibition of Erythrocyte Cation Channels by Erythropoietin
J. Am. Soc. Nephrol.,
November 1, 2003;
14(11):
2750 - 2757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bustamante, F. Roger, M.-L. Bochaton-Piallat, G. Gabbiani, P.-Y. Martin, and E. Feraille
Regulatory volume increase is associated with p38 kinase-dependent actin cytoskeleton remodeling in rat kidney MTAL
Am J Physiol Renal Physiol,
August 1, 2003;
285(2):
F336 - F347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Lang, C. Weigert, S. Braedel, S. Fillon, M. Palmada, E. Schleicher, H.-G. Rammensee, and F. Lang
Inhibition of interferon-gamma expression by osmotic shrinkage of peripheral blood lymphocytes
Am J Physiol Cell Physiol,
January 1, 2003;
284(1):
C200 - C208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Steinbrecher, J. A. Rudolph, G. Luo, and M. B. Cohen
Coordinate upregulation of guanylin and uroguanylin expression by hypertonicity in HT29-18-N2 cells
Am J Physiol Cell Physiol,
December 1, 2002;
283(6):
C1729 - C1737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-R. Shen, C.-Y. Chou, K.-F. Hsu, and J. C. Ellory
Osmotic Shrinkage of Human Cervical Cancer Cells Induces an Extracellular Cl--dependent Nonselective Cation Channel, Which Requires p38 MAPK
J. Biol. Chem.,
November 22, 2002;
277(48):
45776 - 45784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zayzafoon, S. Botolin, and L. R. McCabe
p38 and Activating Transcription Factor-2 Involvement in Osteoblast Osmotic Response to Elevated Extracellular Glucose
J. Biol. Chem.,
September 27, 2002;
277(40):
37212 - 37218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Startchik, D. Morabito, U. Lang, and M. F. Rossier
Control of Calcium Homeostasis by Angiotensin II in Adrenal Glomerulosa Cells through Activation of p38 MAPK
J. Biol. Chem.,
June 28, 2002;
277(27):
24265 - 24273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chen and D. G. Gardner
Osmoregulation of Natriuretic Peptide Receptor Signaling in Inner Medullary Collecting Duct. A REQUIREMENT FOR p38 MAPK
J. Biol. Chem.,
February 15, 2002;
277(8):
6037 - 6043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Goss, L. Jiang, D. H. Vandorpe, D. Kieller, M. N. Chernova, M. Robertson, and S. L. Alper
Role of JNK in hypertonic activation of Cl--dependent Na+/H+ exchange in Xenopus oocytes
Am J Physiol Cell Physiol,
December 1, 2001;
281(6):
C1978 - C1990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Tian, Z. Zhang, and D. M. Cohen
MAPK signaling and the kidney
Am J Physiol Renal Physiol,
October 1, 2000;
279(4):
F593 - F604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Yu and D. W. Choi
Ions, cell volume, and apoptosis
PNAS,
August 15, 2000;
97(17):
9360 - 9362.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Maeno, Y. Ishizaki, T. Kanaseki, A. Hazama, and Y. Okada
Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis
PNAS,
July 12, 2000;
(2000)
140216197.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. Maeno, Y. Ishizaki, T. Kanaseki, A. Hazama, and Y. Okada
From the Cover: Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis
PNAS,
August 15, 2000;
97(17):
9487 - 9492.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|